Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-27318-0
PubMed Identifier: 34876592
Publication URI: http://europepmc.org/abstract/MED/34876592
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723